Merck Says Januvia Effective In Type 2 Diabetes

by Medindia Content Team on  June 12, 2006 at 5:57 PM Diabetes News
RSS Email Print This Page Comment bookmark
Font : A-A+

Merck Says Januvia Effective In Type 2 Diabetes
Merck & Co Inc has said that Januvia, its oral, once-daily medicine for type 2 diabetes has shown promise in combating the disease and had significantly reduced blood sugar levels. This was true when the drug was used alone or in conjunction with two commonly used therapies (metformin or pioglitazone).

Merck presented the results of the Phase III trials at the American Diabetes Association's annual meeting. Treatment with Januvia was also found to improve measures of beta cell function.

Beta cells are found in pancreas and are responsible for producing and releasing insulin. The deficiency of this hormone causes diabetes. Merck said that in the studies, "Januvia had an overall incidence of side effects comparable to placebo and was generally well tolerated."


Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Januvia...a good drug for diabetes, but unfortunately very costly..especially for a country like India. I hope some day pharma companies will think beyond business and bring down the cost of such much needed medicines.

Yes, Januvia is available in Indian markets, but you should always consult your doctor before starting any medications

More News on:

Diabetes Otitis Media Insulin Delivery Devices Diabetes and Exercise Stress Relief Through Alternative Medicine Stress and the Gender Divide Silent Killer Diseases Diabetes Facts Gestational diabetes Top Ten Selling Drugs 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive

Loading...